← Medtronic

What podcasts say about Medtronic

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Medtronic

20 statements · 15 positive · 1 negative · 3 mixed · 1 neutral

  1. Jim CramerPositiveOct 14, 2026· Mad Money w/ Jim Cramer

    Medtronic is preferable to MiniMed for new investment.

    “It's Medtronic. I would buy that one.”

    Listen at 38:31

    Open the episode · Mad Money w/ Jim Cramer 10/14/26
  2. Jim CramerNeutralOct 14, 2026· Mad Money w/ Jim Cramer

    Medtronic trades at fifteen times earnings.

    “15 times earnings for Medtronic.”

    Listen at 38:34

    Open the episode · Mad Money w/ Jim Cramer 10/14/26
  3. Jim CramerPositiveOct 14, 2026· Mad Money w/ Jim Cramer

    Medtronic’s stock is expected to begin rising.

    “now it's going to start going up.”

    Listen at 38:39

    Open the episode · Mad Money w/ Jim Cramer 10/14/26
  4. Cramer likes Medtronic but recommends buying gradually at lower prices.

    “I like Medtronic, but I got to tell you, at 14 times earnings, I don't know what supports it. I buy a little and then wait a little more until it goes down.”

    Listen at 9:36

    Open the episode · Mad Money w/ Jim Cramer 10/1/26
  5. Buy a small Medtronic position and wait for a lower price.

    “I buy a little and then wait a little more until it goes down.”

    Listen at 9:41

    Open the episode · Mad Money w/ Jim Cramer 10/1/26
  6. Jim CramerPositiveSep 8, 2026· Mad Money w/ Jim Cramer

    Medtronic’s business has substantially improved year over year.

    “It is a vastly improved year-over-year business.”

    Listen at 5:15

    Open the episode · 'Mad Money w/ Jim Cramer 9/8/26
  7. Medtronic beat quarterly earnings and revenue estimates and raised fiscal 2027 guidance.

    “Medtronic added around 1.5% after topping analysts' quarterly earnings and revenue estimates and raising fiscal 2027 guidance.”

    Listen at 7:07

    Open the episode · Mulling Tech Earnings, Investors Watch Oil, Yields
  8. Jim CramerNegativeMay 29, 2026· Mad Money w/ Jim Cramer

    Cramer declines to recommend buying Medtronic before its earnings report.

    “I wish I could be aggressive in recommending Medtronic right on Monday morning, but I can't.”

    Listen at 7:22

    Open the episode · Mad Money w/ Jim Cramer 5/29/26
  9. Cramer may choose Medtronic after reviewing its upcoming earnings.

    “Let's look at Medtronic after they report. And then that may be the one that we pull the trigger on.”

    Listen at 35:18

    Open the episode · Mad Money w/ Jim Cramer 5/29/26
  10. Jim CramerPositiveMar 26, 2026· Mad Money w/ Jim Cramer

    Medtronic is inexpensive at fifteen times earnings.

    “By the way, it's 15 times earnings. That's very inexpensive.”

    Listen at 9:05

    Open the episode · Mad Money w/ Jim Cramer 3/26/26
  11. Jim CramerPositiveMar 26, 2026· Mad Money w/ Jim Cramer

    Medtronic is inexpensive at fifteen times earnings

    “it's 15 times earnings. That's very inexpensive.”

    Listen at 9:05

    Open the episode · Mad Money w/ Jim Cramer 3/26/26
  12. Jim CramerPositiveMar 26, 2026· Mad Money w/ Jim Cramer

    Cramer recommends buying more Medtronic

    “I would buy more, Tony.”

    Listen at 9:08

    Open the episode · Mad Money w/ Jim Cramer 3/26/26
  13. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Medtronic's diabetes spinoff makes the remaining company more attractive.

    “spinning this off makes, I think, the old Medtronic much more enticing.”

    Listen at 20:45

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  14. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Medtronic can focus on cardiovascular, neuroscience, and medical-surgical businesses.

    “Medtronic can now focus on its three remaining businesses”

    Listen at 23:01

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  15. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Medtronic is resistant to recession.

    “this thing's recession-proof.”

    Listen at 25:40

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  16. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Medtronic shares are inexpensive relative to earnings estimates.

    “stock's cheap. It's trading 16 times this year's earnings estimates, less than 15 times next year's numbers.”

    Listen at 26:02

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  17. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Cramer is much more bullish on Medtronic after the diabetes separation.

    “I am much more bullish on this stock than I have been in ages.”

    Listen at 26:20

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  18. Jim CramerPositiveMar 10, 2026· Mad Money w/ Jim Cramer

    Medtronic is too cheap for investors to ignore.

    “At these levels, I think the stock's simply too cheap to ignore.”

    Listen at 26:27

    Open the episode · Mad Money w/ Jim Cramer 3/10/26
  19. Jeff MarthaPositiveJan 13, 2026· Mad Money w/ Jim Cramer

    Medtronic’s AI-assisted colonoscopy has performed very successfully diagnostically.

    “the AI has been a home run for this diagnostic.”

    Listen at 18:07

    Open the episode · Mad Money w/ Jim Cramer 1/12/26
  20. Jeff MarthaPositiveJan 13, 2026· Mad Money w/ Jim Cramer

    Pulse-field ablation will improve Medtronic’s gross margin over time.

    “you're going to see it impact positively our gross margin as well.”

    Listen at 20:33

    Open the episode · Mad Money w/ Jim Cramer 1/12/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.